APA

Vazquez M. L., Kaila N., Strohbach J. W., Trzupek J. D., Brown M. F., Flanagan M. E., Mitton-Fry M. J., Johnson T. A., TenBrink R. E., Arnold E. P., Basak A., Heasley S. E., Kwon S., Langille J., Parikh M. D., Griffin S. H., Casavant J. M., Duclos B. A., Fenwick A. E., Harris T. M., Han S., Caspers N., Dowty M. E., Yang X., Banker M. E., Hegen M., Symanowicz P. T., Li L., Wang L., Lin T. H., Jussif J., Clark J. D., Telliez J., Robinson R. P. & Unwalla R. (20190218). Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases. : Journal of medicinal chemistry.

Chicago

Vazquez Michael L, Kaila Neelu, Strohbach Joseph W, Trzupek John D, Brown Matthew F, Flanagan Mark E, Mitton-Fry Mark J, Johnson Timothy A, TenBrink Ruth E, Arnold Eric P, Basak Arindrajit, Heasley Steven E, Kwon Soojin, Langille Jonathan, Parikh Mihir D, Griffin Sarah H, Casavant Jeffrey M, Duclos Brian A, Fenwick Ashley E, Harris Thomas M, Han Seungil, Caspers Nicole, Dowty Martin E, Yang Xin, Banker Mary Ellen, Hegen Martin, Symanowicz Peter T, Li Li, Wang Lu, Lin Tsung H, Jussif Jason, Clark James D, Telliez Jean-Baptiste, Robinson Ralph P and Unwalla Ray. 20190218. Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases. : Journal of medicinal chemistry.

Harvard

Vazquez M. L., Kaila N., Strohbach J. W., Trzupek J. D., Brown M. F., Flanagan M. E., Mitton-Fry M. J., Johnson T. A., TenBrink R. E., Arnold E. P., Basak A., Heasley S. E., Kwon S., Langille J., Parikh M. D., Griffin S. H., Casavant J. M., Duclos B. A., Fenwick A. E., Harris T. M., Han S., Caspers N., Dowty M. E., Yang X., Banker M. E., Hegen M., Symanowicz P. T., Li L., Wang L., Lin T. H., Jussif J., Clark J. D., Telliez J., Robinson R. P. and Unwalla R. (20190218). Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases. : Journal of medicinal chemistry.

MLA

Vazquez Michael L, Kaila Neelu, Strohbach Joseph W, Trzupek John D, Brown Matthew F, Flanagan Mark E, Mitton-Fry Mark J, Johnson Timothy A, TenBrink Ruth E, Arnold Eric P, Basak Arindrajit, Heasley Steven E, Kwon Soojin, Langille Jonathan, Parikh Mihir D, Griffin Sarah H, Casavant Jeffrey M, Duclos Brian A, Fenwick Ashley E, Harris Thomas M, Han Seungil, Caspers Nicole, Dowty Martin E, Yang Xin, Banker Mary Ellen, Hegen Martin, Symanowicz Peter T, Li Li, Wang Lu, Lin Tsung H, Jussif Jason, Clark James D, Telliez Jean-Baptiste, Robinson Ralph P and Unwalla Ray. Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases. : Journal of medicinal chemistry. 20190218.